UNSPSC 51294900: Antidepressant sulfur compounds

Antidepressant drugs made from inorganic or organic compounds that contain sulfur as an integral part of the molecule.

UNSPSC 51294900 Antidepressant sulfur compounds (Class) shows minimal alignment between its nominal scope and actual state and local procurement activity. The three most recent opportunities tagged under this code—Seminole County's naloxone and drug deactivation systems procurement, the Texas HHS Commission's direct-to-manufacturer prescription program RFI, and the Minnesota Multistate Cooperative Purchasing Alliance's generic multi-source pharmaceuticals and OTC products RFP—are all pharmaceutical or medical supply acquisitions with no connection to antidepressant sulfur compounds specifically. State and local buying under this code, when active at all, appears to span county health departments, state health agencies, and cooperative purchasing organizations procuring finished pharmaceuticals, medical countermeasures, and OTC products for public health and community health programs rather than chemical compounds or raw materials.

Recent activity is geographically dispersed: Seminole County, Florida (IFB for naloxone and drug deactivation systems, due July 26, 2023); Texas Health and Human Services Commission (RFI on direct-to-manufacturer prescriptions, posted April 3, 2026); and Minnesota Department of Administration on behalf of MMCAP and Oregon (RFP for generic pharmaceuticals and OTC products, due March 26, 2026). The code shows no meaningful recent contracting activity in its stated commodity area and appears to be a misclassification or legacy taxonomy assignment for modern pharmaceutical procurement. Firms evaluating this code should verify whether the actual commodity or service they offer aligns with finished-goods pharmaceutical distribution rather than sulfur-compound chemistry, as the current tag produces little signal for targeted pursuit.